🇺🇸 FDA
Patent

US 7582281

Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging

granted A61KA61K51/04A61K51/0478

Quick answer

US patent 7582281 (Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging) held by The Board of Regents of the University of Texas System expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K51/04, A61K51/0478, A61K51/0491, A61K51/0497